Lv1
70 积分 2023-01-29 加入
[Expert consensus on the diagnosis and treatment of advanced non-small cell lung cancer with EGFR PACC mutations (2025 edition)]
1个月前
已完结
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
1个月前
已完结
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study
2个月前
已完结
Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors
1年前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
1年前
已完结
Toxicities From Antibody-Drug Conjugates
1年前
已完结
Chemotherapy and Osimertinib Combination Should Not Be the First-Line Treatment for All Advanced EGFR+ NSCLC
1年前
已完结
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses
1年前
已完结
TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes anti-tumor immunity
1年前
已完结
Lung cancer oncogene-directed therapy, fertility and pregnancy
1年前
已关闭
皖公网安备34019202002308
